Neonatal Monosodium Glutamate Treatment Alters Both the Activity and the Sensitivity of the Rat Hypothalamo-pituitary-adrenocortical Axis
Overview
Affiliations
We have investigated the effects of monosodium glutamate (MSG) lesioning of the arcuate nucleus on both central and peripheral components of the hypothalamo-pituitary-adrenocortical (HPA) axis under basal conditions and under acute and chronic stress. Plasma ACTH levels were lower in MSG-lesioned rats (27 +/- 7 pg/ml) compared with controls (71 +/- 18 pg/ml) while corticosterone levels were elevated (523 +/- 84 ng/ml compared with 176 +/- 34 ng/ml). Quantitative in situ hybridization histochemistry revealed that corticotrophin-releasing factor mRNA levels in the medial parvocellular part of the hypothalamic paraventricular nucleus were significantly lower in MSG-treated rats. MSG lesioning resulted in an enhanced response of corticosterone to restraint stress (1309 +/- 92 ng/ml compared with 628 +/- 125 ng/ml in sham-lesioned animals), while ACTH responses to restraint stress in MSG-lesioned and sham-MSG groups were not significantly different (160 +/- 24 pg/ml and 167 +/- 24 pg/ml respectively). These data suggest that MSG-lesioned rats have an increased adrenocortical sensitivity. In rats subjected to the chronic osmotic stimulus of drinking 2% saline for 12 days, plasma ACTH levels were significantly reduced (15 +/- 5 pg/ml) and the ACTH and corticosterone responses to restraint stress were eliminated. ACTH levels were also reduced in MSG-treated animals given 2% saline and the ACTH response to acute stress remained absent in these animals. However, a robust corticosterone response to restraint stress was observed in saline-treated MSG-lesioned rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Collison K, Zaidi M, Maqbool Z, Saleh S, Inglis A, Makhoul N BMC Genomics. 2011; 12:555.
PMID: 22078008 PMC: 3238303. DOI: 10.1186/1471-2164-12-555.
Perello M, Console G, Gaillard R, Spinedi E Endocrine. 2010; 37(3):497-506.
PMID: 20960174 DOI: 10.1007/s12020-010-9335-3.
Seo H, Ham H, Jin H, Lee W, Hwang H, Park S Korean J Physiol Pharmacol. 2010; 14(4):213-21.
PMID: 20827335 PMC: 2933437. DOI: 10.4196/kjpp.2010.14.4.213.
Leitner C, Bartness T Brain Res. 2009; 1292:38-51.
PMID: 19643091 PMC: 3995981. DOI: 10.1016/j.brainres.2009.07.062.
Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.
Collison K, Maqbool Z, Saleh S, Inglis A, Makhoul N, Bakheet R J Lipid Res. 2008; 50(8):1521-37.
PMID: 19001666 PMC: 2724042. DOI: 10.1194/jlr.M800418-JLR200.